Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: NCT03421379 Eligibility Criteria

Page standards status: Informative
Metadata
Title NCT03421379 Eligibility Criteria
Identifier 267225
Steward (Publisher) Computable Publishing LLC
Description

Inclusion Criteria:

  • Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)
  • Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D
  • Hemoglobin A1c (HbA1c) ≤10% Exclusion Criteria:
  • Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month
  • Have received a total daily dose of insulin >1.2 units per kilogram (U/kg)
Copyright

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
Generated using version 0.5.6 of the sample-content-ig Liquid templates